1. Sensorion Appoints Pharmaceutical Industry Veteran Scott D. Myers as Chairman

    Sensorion Appoints Pharmaceutical Industry Veteran Scott D. Myers as Chairman

    Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, announces the appointment of Scott D. Myers as Chairman of its Board of Directors and Independent Director...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. I am thrilled to be taking on the role of Chairman at this exciting phase of Sensorion's development. I look forward to working with the Board and management to further advance Sensorion's pioneering work to develop novel therapies to restore, treat and prevent hearing loss disorders.
    2. I am proud to have been Chairman of Sensorion. The Company has grown and developed its exciting pipeline of novel therapies for hearing loss disorders. I look forward to watching Sensorion's continued success.
  3. Topics Mentioned